The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris

Anna Sinistro, Valentina Calabresi, Francesca Lupi, Francesco Sera, Alessandra Frezzolini, Marina Ruffelli, Ornella De Pità, Diana Camaioni, Giuseppe Cianchini, Giovanni Di Zenzo

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris'. Together they form a unique fingerprint.

Medicine & Life Sciences